These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 20816369)
1. When the evidence is weak, caution should be applied. Lancet Oncol; 2010 Sep; 11(9):805. PubMed ID: 20816369 [No Abstract] [Full Text] [Related]
2. Trastuzumab for early breast cancer. Stuart NS; Bishop J; Bale C Lancet; 2006 Jan; 367(9505):107-8. PubMed ID: 16413865 [No Abstract] [Full Text] [Related]
3. First MAb approved for treatment of metastatic breast cancer. Brenner TL; Adams VR J Am Pharm Assoc (Wash); 1999; 39(2):236-8. PubMed ID: 10079656 [No Abstract] [Full Text] [Related]
4. New breast cancer drug. Harv Womens Health Watch; 1998 Nov; 6(3):7. PubMed ID: 9814134 [No Abstract] [Full Text] [Related]
5. Genentech's anticancer Mab expected by November. Robertson D Nat Biotechnol; 1998 Jul; 16(7):615. PubMed ID: 9661186 [No Abstract] [Full Text] [Related]
6. NICE approves trastuzumab for early stage breast cancer. Mayor S BMJ; 2006 Jun; 332(7555):1409. PubMed ID: 16777868 [No Abstract] [Full Text] [Related]
7. Avastin's uncertain future in breast cancer treatment. Twombly R J Natl Cancer Inst; 2011 Mar; 103(6):458-60. PubMed ID: 21393607 [No Abstract] [Full Text] [Related]
9. Oh, Canada: Public outcry pushed demand for trastuzumab for early-stage breast cancer. Smith M J Natl Cancer Inst; 2005 Sep; 97(18):1327. PubMed ID: 16174852 [No Abstract] [Full Text] [Related]
10. Roche responds to the 'Herceptin or deception' article. Petersen S N Z Med J; 2006 Jul; 119(1237):U2069; author reply U2069. PubMed ID: 16862210 [No Abstract] [Full Text] [Related]
11. Lapatinib moves forward in inflammatory and early HER2-positive breast cancer trials. Tuma RS J Natl Cancer Inst; 2007 Mar; 99(5):348-9. PubMed ID: 17341725 [No Abstract] [Full Text] [Related]
12. Herceptin and early breast cancer: a moment for caution. Lancet; 2005 Nov; 366(9498):1673. PubMed ID: 16291043 [No Abstract] [Full Text] [Related]
16. Neutrophil elastase predicts trastuzumab responsiveness in metastatic breast cancer. Yamashita J; Akizuki M; Jotsuka T; Harao M; Nakano S Breast J; 2006; 12(3):288. PubMed ID: 16684339 [No Abstract] [Full Text] [Related]
17. A "bureausceptic" view of cancer drug rationing. Crown J Lancet; 2001 Nov; 358(9294):1660. PubMed ID: 11728537 [No Abstract] [Full Text] [Related]
18. Trastuzumab and capecitabine for metastatic breast cancer. Med Lett Drugs Ther; 1998 Nov; 40(1039):106-8. PubMed ID: 9814369 [No Abstract] [Full Text] [Related]